Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jsbmb.2015.12.002PMID 26709138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of vitamin D in reducing cancer risk and progression

  2014cited by this paper
• p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.

  2014cited by this paper
• Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.

  2014cited by this paper
• Vitamin D and cancer: the promise not yet fulfilled

  2014cited by this paper
• Prostate cancer biomarkers: an update.

  2014cited by this paper
• Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)‐protopanaxadiol

  2014cited by this paper
• 20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer

  2014cited by this paper
• VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells

  2014cited by this paper
• Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer.

  2013cited by this paper
• Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

  2013cited by this paper
• Cancer incidence, mortality and survival trends in Canada, 1970-2007.

  2013cited by this paper
• Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

  2013cited by this paper
• 20(S)‐protopanaxadiol‐aglycone downregulation of the full‐length and splice variants of androgen receptor

  2013cited by this paper
• Screening for prostate cancer.

  2013cited by this paper
• A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer

  2012cited by this paper
• Vitamin D3 cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial‐mediated apoptosis and necrosis

  2012cited by this paper
• Cytochrome P450 3A-Mediated Microsomal Biotransformation of 1α,25-Dihydroxyvitamin D3 in Mouse and Human Liver: Drug-Related Induction and Inhibition of Catabolism

  2012cited by this paper
• Cytochromes P450 are essential players in the vitamin D signaling system.

  2011cited by this paper
• Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.

  2011cited by this paper
• Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

  2011cited by this paper
• Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

  2011cited by this paper
• Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer

  2010cited by this paper
• Autocrine and paracrine actions of vitamin d.

  2010cited by this paper
• Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.

  2010cited by this paper
• CYP24A1 inhibition enhances the antitumor activity of calcitriol.

  2010cited by this paper
• Vitamin D for cancer prevention: global perspective.

  2009cited by this paper
• Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression.

  2009cited by this paper
• Ginseng compounds: an update on their molecular mechanisms and medical applications.

  2009cited by this paper
• Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy

  2009cited by this paper
• Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts.

  2009cited by this paper
• A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors

  2009cited by this paper
• Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.

  2008cited by this paper
• Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

  2008cited by this paper
• Experimental therapy of prostate cancer with novel natural product anti‐cancer ginsenosides

  2008cited by this paper
• 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action

  2008cited by this paper
• Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues.

  2008cited by this paper
• Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.

  2007cited by this paper
• Vitamin D and calcium supplementation reduces cancer risk : results of a randomized trial 1 , 2

  2007cited by this paper
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  2007cited by this paper
• A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors

  2007cited by this paper
• Antiestrogenic effect of 20S‐protopanaxadiol and its synergy with tamoxifen on breast cancer cells

  2007cited by this paper
• In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng

  2007cited by this paper
• Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3.

  2007cited by this paper
• Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia

  2006cited by this paper
• Intakes of calcium and vitamin D and breast cancer risk in women.

  2006cited by this paper
• Effect of Calcitriol on Prostate-Specific Antigen In vitro and in Humans

  2006cited by this paper
• Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity

  2005cited by this paper
• Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

  2005cited by this paper
• Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.

  2005cited by this paper
• Pharmacokinetics of 1α,25-Dihydroxyvitamin D3 in Normal Mice after Systemic Exposure to Effective and Safe Antitumor Doses

  2004cited by this paper
• Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

  2004cited by this paper
• Androgen receptor (AR) coregulators: an overview.

  2002cited by this paper
• Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.

  2002cited by this paper
• Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

  2001cited by this paper
• Anti-proliferative effect of ginseng saponins on human prostate cancer cell line.

  2000cited by this paper
• Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.

  1999cited by this paper
• Liarozole Acts Synergistically with 1α,25-Dihydroxyvitamin D3 to Inhibit Growth of DU 145 Human Prostate Cancer Cells by Blocking 24-Hydroxylase Activity.

  1999cited by this paper
• Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.

  1997cited by this paper
• Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.

  1995cited by this paper

• 20(S)-protopanaxadiol inhibits proliferation and induces apoptosis of acute myeloid leukemia cells via targeting Bcl-XL and MCL-1

  2025cites this paper
• Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes

  2024cites this paper
• Rare ginsenosides: A unique perspective of ginseng research

  2024cites this paper
• Role of vitamin D in targeting cancer and cancer stem cell populations and its therapeutic implications

  2022cites this paper
• 1α,25-dihydroxyvitamin D3 Synergistically Enhances Anticancer Effects of Ginsenoside Rh2 in Human Prostate Cancer Cells.

  2021cites this paper
• Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents

  2021cites this paper
• Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer

  2021cites this paper
• Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities

  2020cites this paper
• Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification.

  2020cites this paper
• Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets

  2020cites this paper
• NNK-mediated upregulation of DEPDC1 stimulates the progression of oral squamous cell carcinoma by inhibiting CYP27B1 expression.

  2020cites this paper
• Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D3 and Its Natural Derivatives

  2020cites this paper
• Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling

  2020cites this paper
• Zinc, ω-3 polyunsaturated fatty acids and vitamin D: An essential combination for prevention and treatment of cancers.

  2020cites this paper
• Pharmacokinetic interaction of calcitriol with 20(S)‐protopanaxadiol in mice: Determined by LC/MS analysis

  2019cites this paper
• Fibrin matrix containing high-dose calcitriol promotes the apoptosis of gastric cancer cells by sustainably releasing calcitrol and D-dimer

  2019cites this paper
• The correlation between low vitamin D status and renal interleukin-6/STAT3 hyper-activation in patients with clear cell renal cell carcinoma.

  2019cites this paper
• Vitamin D3 regulates apoptosis and proliferation in the testis of D-galactose-induced aged rat model

  2019cites this paper
• Formulation and Characterization of Novel Dry Suspension and Dry Emulsion of 20(S)-Protopanaxadiol

  2019cites this paper
• Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms.

  2018cites this paper
• 20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors

  2018cites this paper
• Effect of Bioactive Nutriments in Health and Disease: The Role of Epigenetic Modifications

  2017cites this paper
• 20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway

  2017cites this paper
• Vitamin D deficiency impairs testicular development and spermatogenesis in mice.

  2017cites this paper
• 20(S)-Protopanaxadiol Phospholipid Complex: Process Optimization, Characterization, In Vitro Dissolution and Molecular Docking Studies

  2016cites this paper
• Intestinal bacterium-derived cyp27a1 prevents colon cancer cell apoptosis.

  2016cites this paper
• Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression.

  2016cites this paper